TCL Archive Supreme Court Decision Means FTC Scrutiny As Costly Oncology Drugs Go Off-Patent June 21, 2013
TCL Archive U.S., Canada Begin ExCel Trial To Evaluate Aromasin For Breast Cancer Prevention April 29, 2005
TCL Archive Also HHS Inspector General is reviewing Lester Crawford’s departure from FDA. October 28, 2005